Dr. Inderjit Mehmi, MD
Claim this profileThe Angeles Clinic and Research Institute
Studies Melanoma
Studies Non-Small Cell Lung Cancer
9 reported clinical trials
12 drugs studied
Area of expertise
1Melanoma
Stage IV
Stage III
EGFR negative
2Non-Small Cell Lung Cancer
Stage IV
EGFR negative
ALK negative
Affiliated Hospitals
Clinical Trials Inderjit Mehmi, MD is currently running
Tumor-Treating Fields + Immunotherapy
for Uveal Melanoma
This trial is testing a new cancer treatment that uses electric fields to stop cancer cell growth. It targets patients with metastatic uveal melanoma, who often do not respond well to current treatments. The treatment works by boosting the immune system to help fight the cancer.
Recruiting1 award Phase 17 criteria
Brentuximab Vedotin + Pembrolizumab
for Advanced Cancers
This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer. There will be several different types of cancer studied in the trial. The cancer must have spread to other parts of the body (metastatic). The study will also find out what side effects occur. A side effect is anything the treatment does besides treat cancer. This is a multi-cohort study.
Recruiting1 award Phase 27 criteria
More about Inderjit Mehmi, MD
Clinical Trial Related2 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Inderjit Mehmi, MD has experience with
- Pembrolizumab
- Nivolumab
- TBX-3400
- Ipilimumab
- Nivolumab + Relatlimab Fixed-dose Combination (FDC)
- Brentuximab Vedotin
Breakdown of trials Inderjit Mehmi, MD has run
Melanoma
Non-Small Cell Lung Cancer
Tumors
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Inderjit Mehmi, MD specialize in?
Inderjit Mehmi, MD focuses on Melanoma and Non-Small Cell Lung Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Inderjit Mehmi, MD currently recruiting for clinical trials?
Yes, Inderjit Mehmi, MD is currently recruiting for 7 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Inderjit Mehmi, MD has studied deeply?
Yes, Inderjit Mehmi, MD has studied treatments such as Pembrolizumab, Nivolumab, TBX-3400.
What is the best way to schedule an appointment with Inderjit Mehmi, MD?
Apply for one of the trials that Inderjit Mehmi, MD is conducting.
What is the office address of Inderjit Mehmi, MD?
The office of Inderjit Mehmi, MD is located at: The Angeles Clinic and Research Institute, Los Angeles, California 90025 United States. This is the address for their practice at the The Angeles Clinic and Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.